Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ProTreatment Helsinge-Tisvilde ApS
APS
Active
CVR 43920855
Frederiksborgvej 16
Physiotherapy activities · NACE 8695
Est. 2023
2 employees
www.protreatment.dk
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 2M
+127% vs 2023
EBITDA margin
65.1%
+110% vs 2023
Equity ratio
-3.6%
Financial strength
Net profit 2024
DKK -150K
+51% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
1M
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 2M
+127%
EBITDA
DKK 1,3M
+110%
Net profit
DKK -150K
+51%
Total assets
DKK 11,4M
-4%
Equity
DKK -413K
-57%
Employees
2
—
Company information
Legal name
ProTreatment Helsinge-Tisvilde ApS
CVR number
43920855
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
15. marts 2023
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller den samlede direktion.
Company purpose
Selskabets formål er at drive fysioterapeutklinik samt enhver virksomhed i hermed stående forbindelse.
Contact
Address
Frederiksborgvej 16
Phone
+4548795304
Email
helsinge@protreatment.dk
Website
www.protreatment.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Physiotherapy activities
Companies in Gribskov
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
1M
2023
2M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
890
2.019
Staff expenses
-263
-689
EBITDA
626
1.314
Depreciation & amort.
-542
-800
EBIT
84
514
Net financials
-473
-706
Profit before tax
-389
-192
Tax
-85
-42
Net profit
-303
-150
Balance sheet
DKK thousands
Item
2023
2024
Total assets
11.941
11.412
Equity
-263
-413
Long-term debt
10.899
8.611
Short-term debt
1.247
3.107
Total debt
12.146
11.718
Financial ratios
5-year trend
EBITDA margin
65.1%
This company
15.8%
Market median
+312% vs market
2023
2024
Equity ratio
-3.6%
This company
38.2%
Market median
-109% vs market
2023
2024
Return on equity
-14972500.0%
This company
18.4%
Market median
-81372383% vs market
2023
2024
Net profit margin
-7.4%
This company
8.1%
Market median
-191% vs market
2023
2024
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
2023
2024
Debt / equity
28.62×
This company
0.62×
Market median
-4516% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-03-15 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
NS
Nadia Seistrup
Management
Management
2023
—
—
TJ
Thomas Jørgensen
Chief Executive Officer
Chief Executive Officer
2023
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
ProTreatment Holding ApS
Company
100.0%
100.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
ProTreatment Holding ApS
ProTreatment Helsinge-Tisvilde ApS
(this company)
Board network connections
Board members of ProTreatment Helsinge-Tisvilde ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Nadia Seistrup
Management
0 companies
Thomas Jørgensen
Chief Executive Officer
0 companies